SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
SciClone Pharmaceuticals (Holdings) Ltd
Revenue
SciClone Pharmaceuticals (Holdings) Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
Revenue
¥3.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is SciClone Pharmaceuticals (Holdings) Ltd's Revenue?
Revenue
3.2B
CNY
Based on the financial report for Dec 31, 2023, SciClone Pharmaceuticals (Holdings) Ltd's Revenue amounts to 3.2B CNY.
What is SciClone Pharmaceuticals (Holdings) Ltd's Revenue growth rate?
Revenue CAGR 5Y
18%
Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for SciClone Pharmaceuticals (Holdings) Ltd have been 18% over the past three years , 18% over the past five years .